当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2011年第19期
编号:12164097
两性霉素B新剂型的开发及临床研究进展(1)
http://www.100md.com 2011年7月5日 《中国医药导报》 2011年第19期
     [摘要] 两性霉素B是一种应用较早的多烯类抗真菌药物。其疗效确切,抗菌谱广,是优良的抗深部真菌药物。但由于其严重的毒副作用,限制了两性霉素B的临床应用。目前已有大量研究采用新剂型以提高两性霉素B的治疗指数,降低其毒副作用,且已有产品成功上市。本文就两性霉素B的作用机制,临床应用及其新制剂的开发及应用情况进行回顾和综述。

    [关键词] 两性霉素B;作用机制;临床应用;新剂型

    [中图分类号] R978 [文献标识码] A [文章编号] 1673-7210(2011)07(a)-006-03

    Advance of the clinical administration and new dosage forms of amphotericin B

    LIU Pei1, JIN Hui2

    1.The Third People's Hospital of Dalian City, Dalian 116033, China;2. Children's Hospital of Dalian City, Dalian 116001, China

    [Abstract] Amphotericin B is a kind of multi-vinyl antifungal drug which has a long history of application. It is an excellent deep anti-fungal drug because of its definite curative effect and broad anti-fungal spectrum.However, the use of amphotericin B is limited clinically due to the severe side effects.There have been a lot of researches in recent years using new dosage forms to enhance the therapeutic index and decrease the side effects,and some products have been successfully used clinically. In this paper, the mechanisms of action, clinical administration and new dosage forms of amphotericin B have been summarized. ......
1 2 3下一页

您现在查看是摘要页,全文长 5071 字符